Juan Ramón
Murcia, 30100, Spain
NCT Number: NCT03059576
The purpose of this investigation is to assess the role of the genetic and environmental factor on circadian system, in free living conditions by the use of a female twin population. With the results from this study, the investigators expect to advance in the understanding of the role of the endogenicity of the circadian system variables such as temperature, activity, sleep and timing of food intake as the main cause of the coincidence of the rhythms. However, the investigators expected that some parameters are still dependent on environment to a relevant extent and, hence, amenable to change through external interventions.
Looking for future studies?
Notify Me18 year–70 year
Female
Observational
Murcia, 30100, Spain
Twin studies are a classic in the analysis of the relative contribution of genetic and environmental factors to behavior and other phenotypes. These models are most often used to separate genetic from environmental causes in the family resemblance methodology. These models based on twins have been previously carried out in chronobiology. In fact, during the years 1993 and 1994, Paul Linkowski et al., performed two relevant studies on the circadian system to analyze the relative contributions of hereditary and/or environmental factors of cortisol secretion and blood pressure, respectively, and concluded that genetic factors control some of the characteristics of cortisol and diastolic blood pressure circadian rhythmicity. The heritability of other circadian markers has also demonstrated such as morningness- eveningness (44%), sleep-related variables have also pointed to a relevant role of genetics with heritability estimates of sleep duration between 17% and 55%. However, to the investigators knowledge, the heritability of other relevant chronobiological markers, measured in free living conditions such as body temperature, actigraphy and sleep has not been studied.
These goals will be achieved through a specific approach:
Only the study team can determine whether someone qualifies for participation.
IInclusion Criteria:
Exclusion criteria
Participation was completely voluntary and not remunerated. The subjects were organized into groups of 5 pairs, and were given an appointment at a university facility located in the city center, where informed consent was signed prior to the procedures indicated below. An informational letter was sent to pre-selected individuals. Later a phone call confirmed their availability.
Time frame: Total of 1 week between Visit 1 and 2
Measured using temperature sensor
Time frame: Total of 1 week between Visit 1 and 2
Measured using Pendant Acceleration Data Logger
Time frame: Total of 1 week between Visit 1 and 2
Measured using Pendant Acceleration Data Logger
Time frame: Total of 1 week between Visit 1 and 2
Measured using Pendant Acceleration Data Logger
Time frame: Total of 1 week between Visit 1 and 2
Sleep duration will be computed from self-reported
Time frame: Total of 1 week between Visit 1 and 2
Total energy intake in kcal/day will be computed from 7-day 24-hr dietary recalls
Time frame: Total of 1 week between Visit 1 and 2
Macronutrient and micronutrient intake will be computed from 7-days of self-reported 24-hr dietary recalls
Time frame: Total of 1 week between Visit 1 and 2
Food timing will be self-reported and averaged across 7-days of 24-hr dietary recalls
Time frame: Total of 1 week between Visit 1 and 2
Assessed using the Morningness-Eveningness Questionnaire
Universidad de Murcia
Other
Circadian System Heritability Assessed in Free Living Conditions in a Twin Mediterranean Population
Acronym: MTR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details